Press Releases
-
Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma
Calidi Biotherapeutics, a clinical-stage biotechnology company is pleased to announce that City of Hope has received FDA authorization to proceed with a phase 1 physician-sponsored clinical trial that will deliver Calidi’s cutting-edge oncolytic virotherapy platform, NSC-CRAd-S-pk7 (NeuroNova), to patients with recurrent high-grade glioma.
Aug 1, 2022
-
MicroRNA Agomir Synthesis: Supporting New Drug Research with Cutting-Edge Chemical Synthesis Technology
-
Creative Bioarray Offers Clonality Analysis Service to Accelerate Biopharmaceutical or Biosimilar Development
-
Creative Bioarray Develops Full-service Support for Transgene Mapping
-
Creative Bioarray Has Developed Cell Immortalization Services to Support Potential Drug Development
-
Creative Peptides Delivers Phage Display Services with Versatile Peptide Library
Creative Peptides delivers phage display services with a versatile phage peptide library, hoping to assist researchers in jumpstarting peptide drug screening.
Jul 31, 2022
-
BioIVT Announces Promotion of Dr. Richard Haigh to CEO
BioIVT, a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, announced the promotion of Richard Haigh, PhD, from Chief Operating Officer to Chief Executive Officer effective August 1.
Jul 31, 2022
-
Creative Biogene Released Complete C. elegans Cell Isolation and Culture Services
Creative Biogene released complete C. elegans cell isolation and culture services with high-quality data delivery, as well as in-depth scientific and technical support
Jul 31, 2022
-
Signant Launches Major Telemedicine Platform Innovations to Optimize Remote and Decentralized Clinical Trial Operations
Signant Health, the leader in evidence generation for modern clinical trials, recently released significant updates to its telemedicine platform, Signant SmartSignals Telemedicine. Numerous functionality enhancements, as well as security- and compliance-focused innovations, ensure the platform meets evolving customer and industry needs while supporting ever-changing global regulatory requirements.
Jul 26, 2022
-
World’s first Global Hygiene Summit to take place in Singapore in 2023
The Global Hygiene Summit 2023 is being hosted in Singapore on the 15th and 16th February 2023.
Jul 26, 2022
-
CD ComputaBio Announces the Launch of the GO Enrichment Analysis Service
-
Huateng Pharma Supplies Monodisperse PEGs And Polydisperse PEGs in Large Quantities
-
Creative Proteomics Lipidomics Launches Steroids Analysis Service
-
Pronalyse Announces the Launch of Its Oligonucleotide Characterization Service
-
Creative Proteomics Accelerates Protein Research with Top-Down Proteomics Services
-
U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business
Alliance Pharma closed on the purchase of Drug Development Solutions (an LGC Business Unit).
Jul 25, 2022
-
Biopharma PEG Provides PEG derivatives Applied in PROTAC Linker
-
Profacgen Enables Accelerated Drug Development with One-step 3D-QSAR Workflow
-
Creative BioMart Supports a Comprehensive List of Fluorescent-labeled Recombinant Proteins
-
CD BioGlyco Offers Wide Solutions for Lipid Analysis